Variable | HR (95% CI) | P |
---|---|---|
Gender | Â | Â |
 Male vs female | NA | 0.791 |
LANCL2 gene status | Â | Â |
 Amplification vs no alteration | 2.199 (1.142–4.236) | 0.018 |
EGFR gene status | Â | Â |
 Amplification vs no alteration | NA | 0.805 |
LANCL2 and EGFR genes status | Â | Â |
 Co-amplification vs no alteration | NA | 0.845 |